期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Deep proteome profiling promotes whole proteome characterization and drug discovery for esophageal squamous cell carcinoma
1
作者 Wei liu Yongping Cui +3 位作者 Wen liu Zhihua liu liyan Xu enmin li 《Cancer Biology & Medicine》 SCIE CAS CSCD 2022年第3期273-277,共5页
Proteins are key players in various cellular processes.As the ultimate executors of cellular processes,they play essential roles in linking genotypes to phenotypes.Abnormalities in protein expression and post-translat... Proteins are key players in various cellular processes.As the ultimate executors of cellular processes,they play essential roles in linking genotypes to phenotypes.Abnormalities in protein expression and post-translational modifications(PTMs)are closely associated with the initiation and development of cancer,and they carry biological information inaccessible to genomics and transcriptomics1.Proteomics complements genomic and transcriptomic data,thus enabling comprehensive analysis of cancer pathogenesis and accelerating biomedical research2. 展开更多
关键词 ESOPHAGEAL LINKING CARRY
下载PDF
RIOK1 synergizes with TRIP13 by regulating the E2F-Rb signaling pathway to promote the proliferation of esophageal cancer cells
2
作者 Chengyu li Deyuan Pan +7 位作者 Wan lin Danxia Deng Yingxin Zhou Hui Zhao Feng Pan liyan Xu enmin li lin Long 《Genes & Diseases》 SCIE CSCD 2024年第3期55-58,共4页
Esophageal cancer is one of the leading causes of cancer death in the world,with approximately half of the new cases occurring in China every year.^(1)Esophageal squamous cell carcinoma(ESCC)is the main subtype,accoun... Esophageal cancer is one of the leading causes of cancer death in the world,with approximately half of the new cases occurring in China every year.^(1)Esophageal squamous cell carcinoma(ESCC)is the main subtype,accounting for more than 90%,and the five-year survival rate is less than 10%.Using large-scale genome analysis,many driver mutations and key pathways associated with ESCC have been identified.However,these genomic signatures have not improved the clinical management of EscC patients,or established effective targeted therapy.^(2)Esophageal cancer still lacks representative molecular markers. 展开更多
关键词 cancer ESOPHAGEAL ESOPHAGEAL
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部